Finzati - Logo
AEON logo

AEON Biopharma, Inc.

AEON • Biotechnology
$0.23
▲ +0.00 (+0.22%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$11.95M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.49Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:37 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.23
Change0.22%
Market Cap$11.95M
52W Range0.22 - 1.45
Beta0.64
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.65
Current Ratio0.49
Quick Ratio0.49
Revenue 5Y-100.00%

Investment DNA

How strong this company looks for long-term investors

33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Weak liquidity · 0.49Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 7/24/2023
Industry: Biotechnology
P/B i: -0.20
Debt / Equity i: -0.65
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score4 / 20
Debt / Equity: -0.65
Current Ratio: 0.49
Quick Ratio: 0.49
Status: HighRisk

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Carter Eric G
Transaction: 06/17/2026
BUY
Change
+222,684
Price
Not reported
Filing
06/22/2026
Type
BUY
FISCHER JOST
Transaction: 06/17/2026
BUY
Change
+222,684
Price
Not reported
Filing
06/22/2026
Type
BUY
Forth Marc
Transaction: 06/17/2026
BUY
Change
+222,684
Price
Not reported
Filing
06/22/2026
Type
BUY